Comment
doi: 10.1001/jamainternmed.2016.7991.
Risk and Benefit Information and Use of Aspirin-Reply
Affiliations
- PMID: 28166350
- DOI: 10.1001/jamainternmed.2016.7991
Item in Clipboard
Comment
Risk and Benefit Information and Use of Aspirin-Reply
JAMA Intern Med.
.
No abstract available
Comment on
-
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.JAMA Intern Med. 2016 Aug 1;176(8):1195-204. doi: 10.1001/jamainternmed.2016.2648. JAMA Intern Med. 2016. PMID: 27322595 Review.
-
Risk and Benefit Information and Use of Aspirin.JAMA Intern Med. 2017 Feb 1;177(2):291. doi: 10.1001/jamainternmed.2016.7988. JAMA Intern Med. 2017. PMID: 28166337 No abstract available.
Similar articles
-
Risk and Benefit Information and Use of Aspirin.JAMA Intern Med. 2017 Feb 1;177(2):291. doi: 10.1001/jamainternmed.2016.7988. JAMA Intern Med. 2017. PMID: 28166337 No abstract available.
-
Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.Am Heart J. 2003 Feb;145(2):343-8. doi: 10.1067/mhj.2003.22. Am Heart J. 2003. PMID: 12595854
-
Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg.J Clin Pharmacol. 2016 Apr;56(4):414-21. doi: 10.1002/jcph.608. Epub 2015 Oct 26. J Clin Pharmacol. 2016. PMID: 26239393
-
Aspirin in coronary artery disease: an appraisal of functions and limitations.Dan Med J. 2015 Apr;62(4):B5011. Dan Med J. 2015. PMID: 25872543 Review.
-
Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.Semin Thromb Hemost. 2009 Apr;35(3):295-306. doi: 10.1055/s-0029-1222608. Epub 2009 May 18. Semin Thromb Hemost. 2009. PMID: 19452405 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
